delphi medical consultants limitedEstimated Valuation
£8.3m
Pomanda estimates the enterprise value of DELPHI MEDICAL CONSULTANTS LIMITED at £8.3m based on a Turnover of £8.8m and 0.94x industry multiple (adjusted for size and gross margin).
delphi medical consultants limitedEstimated Valuation
£2.1m
Pomanda estimates the enterprise value of DELPHI MEDICAL CONSULTANTS LIMITED at £2.1m based on an EBITDA of £307k and a 6.98x industry multiple (adjusted for size and gross margin).
delphi medical consultants limitedEstimated Valuation
£3.5m
Pomanda estimates the enterprise value of DELPHI MEDICAL CONSULTANTS LIMITED at £3.5m based on Net Assets of £1.4m and 2.51x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Delphi Medical Consultants LimitedOverview
Delphi Medical Consultants Limited is a live company located in lancashire, BB11 2ED with a Companies House number of 06014150. It operates in the general medical practice activities sector, SIC Code 86210. Founded in November 2006, it's largest shareholder is
acorn recovery projects
with a 100% stake. Delphi Medical Consultants Limited is a established,
mid sized company, Pomanda has estimated its turnover at
£8.8m with
high
growth in recent years.
Pomanda's financial health check has awarded Delphi Medical Consultants Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs
Health Rating3.5out of 5
5 Strong
2 Regular
4 Weak
Size
annual sales of £8.8m, make it larger than the average company (£1.9m)
£8.8m - Delphi Medical Consultants Limited
£1.9m - Industry AVG
Growth
3 year (CAGR) sales growth of 23%, show it is growing at a faster rate (10.5%)
23% - Delphi Medical Consultants Limited
10.5% - Industry AVG
Production
with a gross margin of 74.3%, this company has a lower cost of product (40.1%)
74.3% - Delphi Medical Consultants Limited
40.1% - Industry AVG
Profitability
an operating margin of 2.7% make it less profitable than the average company (3.7%)
2.7% - Delphi Medical Consultants Limited
3.7% - Industry AVG
Employees
with 170 employees, this is above the industry average (21)
170 - Delphi Medical Consultants Limited
21 - Industry AVG
Pay Structure
on an average salary of £33.9k, the company has an equivalent pay structure (£34.6k)
£33.9k - Delphi Medical Consultants Limited
£34.6k - Industry AVG
Efficiency
resulting in sales per employee of £51.8k, this is less efficient (£87k)
£51.8k - Delphi Medical Consultants Limited
£87k - Industry AVG
Debtor Days
it gets paid by customers after 8 days, this is earlier than average (30 days)
8 days - Delphi Medical Consultants Limited
30 days - Industry AVG
Creditor Days
its suppliers are paid after 13 days, this is quicker than average (25 days)
13 days - Delphi Medical Consultants Limited
25 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Delphi Medical Consultants Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 1 weeks, this is less cash available to meet short term requirements (41 weeks)
1 weeks - Delphi Medical Consultants Limited
41 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 56.6%, this is a similar level of debt than the average (55.9%)
56.6% - Delphi Medical Consultants Limited
55.9% - Industry AVG
DELPHI MEDICAL CONSULTANTS LIMITED financials
EXPORT
Delphi Medical Consultants Limited's latest turnover from March 2024 is £8.8 million and the company has net assets of £1.4 million. According to their latest financial statements, Delphi Medical Consultants Limited has 170 employees and maintains cash reserves of £44 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Mar 2010
Turnover
8,810,000
7,953,000
5,347,000
4,705,963
3,806,241
3,781,230
3,640,170
2,980,486
427,404
164,580
3,872,901
1,664,098
1,137,357
1,061,612
988,373
Other Income Or Grants
Cost Of Sales
2,268,000
1,955,000
1,073,000
928,694
1,005,006
1,084,415
796,056
983,067
217,526
95,382
2,203,100
857,672
563,946
438,168
410,821
Gross Profit
6,542,000
5,998,000
4,274,000
3,777,269
2,801,235
2,696,815
2,844,114
1,997,419
209,878
69,198
1,669,802
806,426
573,411
623,444
577,552
Admin Expenses
6,302,000
5,884,000
3,875,000
3,413,909
2,751,187
2,820,993
2,834,121
1,954,435
53,475
69,199
1,747,086
768,078
524,949
613,527
558,140
Operating Profit
240,000
114,000
399,000
363,360
50,048
-124,178
9,993
42,984
156,403
-1
-77,284
38,348
48,462
9,917
19,412
Interest Payable
Interest Receivable
145,000
31,000
1
413
773
711
1,025
675
Pre-Tax Profit
385,000
145,000
399,000
363,360
50,048
-124,178
9,993
42,984
156,403
-76,871
39,121
49,173
10,942
20,088
Tax
2,875
-4,616
-31,281
-9,389
-12,785
-3,064
-5,624
Profit After Tax
385,000
145,000
399,000
363,360
50,048
-121,303
5,377
42,984
125,122
-76,871
29,732
36,388
7,878
14,463
Dividends Paid
Retained Profit
385,000
145,000
399,000
363,360
50,048
-121,303
5,377
42,984
125,122
-76,871
29,732
36,388
7,878
14,463
Employee Costs
5,760,000
5,376,000
3,860,000
3,452,784
2,831,276
3,024,403
3,099,024
2,144,874
1,883,329
85,898
1,429,519
684,982
506,015
390,840
386,358
Number Of Employees
170
173
143
131
2
111
111
68
54
3
56
27
19
15
14
EBITDA*
307,000
138,000
403,000
374,705
61,393
-112,833
20,675
42,984
156,403
-1
-61,380
48,648
58,232
17,711
26,099
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Mar 2010
Tangible Assets
272,000
238,000
34,000
15,069
12,008
23,353
34,698
18,805
23,240
22,932
19,719
14,732
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
272,000
238,000
34,000
15,069
12,008
23,353
34,698
18,805
23,240
22,932
19,719
14,732
Stock & work in progress
Trade Debtors
205,000
569,000
408,000
593,986
74,354
18,200
18,772
161,613
200,664
12,590
349,950
143,114
95,059
72,397
57,370
Group Debtors
2,478,000
2,228,000
1,631,000
1,576,869
1,540,023
1,589,630
1,573,240
169,970
258,065
Misc Debtors
243,000
195,000
112,000
196,777
37,354
39,858
32,530
33,385
Cash
44,000
33,000
73,000
11,395
28,475
125,638
160,750
213
28,827
269
164,796
144,453
139,809
270,123
misc current assets
total current assets
2,970,000
3,025,000
2,224,000
2,379,027
1,680,206
1,773,326
1,785,292
365,181
487,556
12,590
350,219
307,910
239,512
212,206
327,493
total assets
3,242,000
3,263,000
2,258,000
2,394,096
1,692,214
1,796,679
1,819,990
365,181
487,556
12,590
369,024
331,150
262,444
231,925
342,225
Bank overdraft
Bank loan
Trade Creditors
85,000
141,000
40,000
45,252
133,424
24,507
183,458
20,964
189,515
351,510
237,400
197,322
204,169
323,595
Group/Directors Accounts
1,196,000
1,637,000
757,000
886,720
1,269,836
1,489,369
1,262,262
15,798
other short term finances
hp & lease commitments
other current liabilities
554,000
463,000
583,000
983,946
174,136
218,033
188,197
147,723
160,329
total current liabilities
1,835,000
2,241,000
1,380,000
1,915,918
1,577,396
1,731,909
1,633,917
184,485
349,844
351,510
237,400
197,322
204,169
323,595
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
4,924
4,289
5,393
4,415
3,167
total long term liabilities
4,924
4,289
5,393
4,415
3,167
total liabilities
1,835,000
2,241,000
1,380,000
1,915,918
1,577,396
1,731,909
1,633,917
184,485
349,844
356,434
241,689
202,715
208,584
326,762
net assets
1,407,000
1,022,000
878,000
478,178
114,818
64,770
186,073
180,696
137,712
12,590
12,590
89,461
59,729
23,341
15,463
total shareholders funds
1,407,000
1,022,000
878,000
478,178
114,818
64,770
186,073
180,696
137,712
12,590
12,590
89,461
59,729
23,341
15,463
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Mar 2010
Operating Activities
Operating Profit
240,000
114,000
399,000
363,360
50,048
-124,178
9,993
42,984
156,403
-1
-77,284
38,348
48,462
9,917
19,412
Depreciation
67,000
24,000
4,000
11,345
11,345
11,345
10,682
15,904
10,300
9,770
7,794
6,687
Amortisation
Tax
2,875
-4,616
-31,281
-9,389
-12,785
-3,064
-5,624
Stock
Debtors
-66,000
841,000
-216,632
715,901
4,043
23,146
1,259,574
-93,761
446,139
-337,360
206,836
48,055
22,662
15,027
57,370
Creditors
-56,000
101,000
-5,252
-88,172
108,917
-158,951
162,494
-168,551
189,515
-351,510
114,110
40,078
-6,847
-119,426
323,595
Accruals and Deferred Income
91,000
-120,000
-400,946
809,810
-43,897
29,836
40,474
-12,606
160,329
Deferred Taxes & Provisions
-4,924
635
-1,104
978
1,248
3,167
Cash flow from operations
408,000
-722,000
213,434
380,442
122,370
-262,219
-1,040,547
-44,412
28,827
-19,075
-153,471
30,178
16,916
-118,558
289,867
Investing Activities
capital expenditure
-101,000
-228,000
-22,931
-14,406
-45,380
18,805
-11,469
-10,608
-12,983
-12,781
-21,419
Change in Investments
cash flow from investments
-101,000
-228,000
-22,931
-14,406
-45,380
18,805
-11,469
-10,608
-12,983
-12,781
-21,419
Financing Activities
Bank loans
Group/Directors Accounts
-441,000
880,000
-129,720
-383,116
-219,533
227,107
1,246,464
15,798
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
-1,000
822
1,000
interest
145,000
31,000
1
413
773
711
1,025
675
cash flow from financing
-296,000
910,000
-128,898
-383,116
-219,533
227,107
1,246,464
15,798
1
413
773
711
1,025
1,675
cash and cash equivalents
cash
11,000
-40,000
61,605
-17,080
-97,163
-35,112
160,537
-28,614
28,827
-269
-164,527
20,343
4,644
-130,314
270,123
overdraft
change in cash
11,000
-40,000
61,605
-17,080
-97,163
-35,112
160,537
-28,614
28,827
-269
-164,527
20,343
4,644
-130,314
270,123
delphi medical consultants limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for delphi medical consultants limited. Get real-time insights into delphi medical consultants limited's credit score, group structure and payment trends.
Delphi Medical Consultants Limited Competitor Analysis
Perform a competitor analysis for delphi medical consultants limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in BB11 area or any other competitors across 12 key performance metrics.
delphi medical consultants limited Ownership
DELPHI MEDICAL CONSULTANTS LIMITED group structure
Delphi Medical Consultants Limited has no subsidiary companies.
The sole shareholder of Delphi Medical Consultants Limited is Acorn Recovery Projects.
acorn recovery projects
100%
delphi medical consultants limited directors
Delphi Medical Consultants Limited currently has 2 directors.
The longest serving directors include
Mr Richard Jones (Dec 2018) and
Mrs Sallie Bridgen (Mar 2022).
delphi medical consultants limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to delphi medical consultants limited.
delphi medical consultants limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for DELPHI MEDICAL CONSULTANTS LIMITED. This can take several minutes, an email will notify you when this has completed.
delphi medical consultants limitedCompanies House Filings - See Documents
